Review



her2 breast cancer cell lines uacc812  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    ATCC her2 breast cancer cell lines uacc812
    Associations between SGLT1 protein expression levels and clinicopathologic variables of the breast cancer patient cohort.
    Her2 Breast Cancer Cell Lines Uacc812, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 166 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/her2+breast+cancer+cell+lines+uacc812/UACC-812/pmc07191406-105-1-14
    Average 95 stars, based on 166 article reviews
    her2 breast cancer cell lines uacc812 - by Bioz Stars, 2026-10
    95/100 stars

    Images

    1) Product Images from "Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer"

    Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer

    Journal: Disease Markers

    doi: 10.1155/2020/6103542

    Associations between SGLT1 protein expression levels and clinicopathologic variables of the breast cancer patient cohort.
    Figure Legend Snippet: Associations between SGLT1 protein expression levels and clinicopathologic variables of the breast cancer patient cohort.

    Techniques Used: Expressing

    Representative staining of SGLT1 in different subtypes of breast cancer (×100, ×400). (a) Negative immunoreactions. Scale bar: 100 μ m. (b) Positive staining of SGLT1 in luminal-like breast cancer. (c) Positive staining of SGLT1 in HER2+ breast cancer. (d) Positive staining of SGLT1 in basal-like breast cancer.
    Figure Legend Snippet: Representative staining of SGLT1 in different subtypes of breast cancer (×100, ×400). (a) Negative immunoreactions. Scale bar: 100 μ m. (b) Positive staining of SGLT1 in luminal-like breast cancer. (c) Positive staining of SGLT1 in HER2+ breast cancer. (d) Positive staining of SGLT1 in basal-like breast cancer.

    Techniques Used: Staining

    Representative western blot of HER2 and SGLT1 expression levels and quantification relative to actin in UACC812 and SKBR3 cells. UACC812 and SKBR3 cells were treated with HER2 inhibitors (HER2 I), Phlorizin, MG132 alone, or in combination for 48 h. Untreated cells were used as a negative control (NC). (a) A representative WB detection result of three independent experiments was shown. (b) The relative levels of HER2 and SGLT1 protein in UACC812 and SKBR3 cells. Statistically significant differences between groups were displayed; ∗∗∗∗ p < 0.0001; ∗∗∗ p < 0.001; ∗∗ p < 0.01; ∗ p < 0.05.
    Figure Legend Snippet: Representative western blot of HER2 and SGLT1 expression levels and quantification relative to actin in UACC812 and SKBR3 cells. UACC812 and SKBR3 cells were treated with HER2 inhibitors (HER2 I), Phlorizin, MG132 alone, or in combination for 48 h. Untreated cells were used as a negative control (NC). (a) A representative WB detection result of three independent experiments was shown. (b) The relative levels of HER2 and SGLT1 protein in UACC812 and SKBR3 cells. Statistically significant differences between groups were displayed; ∗∗∗∗ p < 0.0001; ∗∗∗ p < 0.001; ∗∗ p < 0.01; ∗ p < 0.05.

    Techniques Used: Western Blot, Expressing, Negative Control

    The curve and column results of the ECAR values for UACC812 and SKBR3 cells. (a) The ECAR values of UACC812 and SKBR3 cells treated with 0, 10, 20, 30, 40, 50, and 60 min, respectively. (b) The ECAR values of each group at 40 min in UACC812 and SKBR3 cells. Statistically significant differences between groups were displayed; ∗∗∗∗ p < 0.0001; ∗∗∗ p < 0.001; ∗∗ p < 0.01.
    Figure Legend Snippet: The curve and column results of the ECAR values for UACC812 and SKBR3 cells. (a) The ECAR values of UACC812 and SKBR3 cells treated with 0, 10, 20, 30, 40, 50, and 60 min, respectively. (b) The ECAR values of each group at 40 min in UACC812 and SKBR3 cells. Statistically significant differences between groups were displayed; ∗∗∗∗ p < 0.0001; ∗∗∗ p < 0.001; ∗∗ p < 0.01.

    Techniques Used:

    Representative western blot of PI3K/Akt/mTOR pathway-related protein expression levels and quantification relative to actin in UACC812 cells. A representative WB detection result of PI3K/Akt/mTOR pathway-related protein expression levels in (a) SGLT1 siRNA and (d) phlorizin treatment. The relative levels of PI3K/Akt/mTOR protein in (b) SGLT1 siRNA and (e) phlorizin treatment. The relative levels of p-PI3K/p-Akt/p-mTOR protein in (c) SGLT1 siRNA and (f) phlorizin treatment. The results shown were representative of at least three independent experiments; ∗∗∗∗ p < 0.0001.
    Figure Legend Snippet: Representative western blot of PI3K/Akt/mTOR pathway-related protein expression levels and quantification relative to actin in UACC812 cells. A representative WB detection result of PI3K/Akt/mTOR pathway-related protein expression levels in (a) SGLT1 siRNA and (d) phlorizin treatment. The relative levels of PI3K/Akt/mTOR protein in (b) SGLT1 siRNA and (e) phlorizin treatment. The relative levels of p-PI3K/p-Akt/p-mTOR protein in (c) SGLT1 siRNA and (f) phlorizin treatment. The results shown were representative of at least three independent experiments; ∗∗∗∗ p < 0.0001.

    Techniques Used: Western Blot, Expressing

    CCK-8 assays for the effect of SGLT1 expression on cell proliferation in UACC812 and SKBR3 cells. (a) The cell viability of UACC812 and SKBR3 cells relative to negative control groups after 0, 12, 24, 36, and 48 h treatment, respectively. (b) The cell viability of each group relative to negative control groups at 48 h in UACC812 and SKBR3 cells. Statistically significant differences between groups were displayed; ∗∗∗∗ p < 0.0001; ∗∗∗ p < 0.001; ∗∗ p < 0.01; ∗ p < 0.05.
    Figure Legend Snippet: CCK-8 assays for the effect of SGLT1 expression on cell proliferation in UACC812 and SKBR3 cells. (a) The cell viability of UACC812 and SKBR3 cells relative to negative control groups after 0, 12, 24, 36, and 48 h treatment, respectively. (b) The cell viability of each group relative to negative control groups at 48 h in UACC812 and SKBR3 cells. Statistically significant differences between groups were displayed; ∗∗∗∗ p < 0.0001; ∗∗∗ p < 0.001; ∗∗ p < 0.01; ∗ p < 0.05.

    Techniques Used: CCK-8 Assay, Expressing, Negative Control

    Cox's univariate regression analysis of the patient survival in breast cancer with respect to clinical parameters and cancer biological factors.
    Figure Legend Snippet: Cox's univariate regression analysis of the patient survival in breast cancer with respect to clinical parameters and cancer biological factors.

    Techniques Used:

    Kaplan-Meier survival analysis according to SGLT1 expression in the whole cohort and HER2+ subtype of breast cancer patients (log-rank test). Association of SGLT1 expression levels with (a) DFS and (c) OS in the whole cohort of breast cancer patients. Association of SGLT1 expression levels with (b) DFS and (d) OS in HER2+ breast cancer patients.
    Figure Legend Snippet: Kaplan-Meier survival analysis according to SGLT1 expression in the whole cohort and HER2+ subtype of breast cancer patients (log-rank test). Association of SGLT1 expression levels with (a) DFS and (c) OS in the whole cohort of breast cancer patients. Association of SGLT1 expression levels with (b) DFS and (d) OS in HER2+ breast cancer patients.

    Techniques Used: Expressing

    Kaplan-Meier survival analysis according to SGLT1 expression in basal-like, luminal-like, and luminal-HER2+ subtype of breast cancer patients (log-rank test). Association of SGLT1 expression levels with (a) DFS and (d) OS in basal-like breast cancer patients. Association of SGLT1 expression levels with (b) DFS and (e) OS in luminal-like breast cancer patients. Association of SGLT1 expression levels with (c) DFS and (f) OS in LuminalHER2+ breast cancer patients.
    Figure Legend Snippet: Kaplan-Meier survival analysis according to SGLT1 expression in basal-like, luminal-like, and luminal-HER2+ subtype of breast cancer patients (log-rank test). Association of SGLT1 expression levels with (a) DFS and (d) OS in basal-like breast cancer patients. Association of SGLT1 expression levels with (b) DFS and (e) OS in luminal-like breast cancer patients. Association of SGLT1 expression levels with (c) DFS and (f) OS in LuminalHER2+ breast cancer patients.

    Techniques Used: Expressing

    Cox's multivariate regression analysis of the patient survival in breast cancer with respect to clinical parameters and cancer biological factors.
    Figure Legend Snippet: Cox's multivariate regression analysis of the patient survival in breast cancer with respect to clinical parameters and cancer biological factors.

    Techniques Used:

    Related Articles

    Expressing:

    Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer
    Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.. UACC812 and SKBR3 cells were cultured in DMEM and RPMI-1640, respectively, supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin.UACC812 and SKBR3 cells were cultured in DMEM and RPMI-1640, respectively, supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin.

    Staining:

    Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer
    Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.. UACC812 and SKBR3 cells were cultured in DMEM and RPMI-1640, respectively, supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin.UACC812 and SKBR3 cells were cultured in DMEM and RPMI-1640, respectively, supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin.

    Western Blot:

    Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer
    Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.. UACC812 and SKBR3 cells were cultured in DMEM and RPMI-1640, respectively, supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin.UACC812 and SKBR3 cells were cultured in DMEM and RPMI-1640, respectively, supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin.

    Negative Control:

    Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer
    Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.. UACC812 and SKBR3 cells were cultured in DMEM and RPMI-1640, respectively, supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin.UACC812 and SKBR3 cells were cultured in DMEM and RPMI-1640, respectively, supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin.

    CCK-8 Assay:

    Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer
    Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.. UACC812 and SKBR3 cells were cultured in DMEM and RPMI-1640, respectively, supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin.UACC812 and SKBR3 cells were cultured in DMEM and RPMI-1640, respectively, supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin.



    Similar Products

    her2 breast cancer cell lines uacc812  (ATCC)
    95
    ATCC her2 breast cancer cell lines uacc812
    Associations between SGLT1 protein expression levels and clinicopathologic variables of the breast cancer patient cohort.
    Her2 Breast Cancer Cell Lines Uacc812, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/her2+breast+cancer+cell+lines+uacc812/UACC-812/pmc07191406-105-1-14
    Average 95 stars, based on 1 article reviews
    her2 breast cancer cell lines uacc812 - by Bioz Stars, 2026-10
    95/100 stars
    		  Buy from Supplier
    her2 positive breast cancer cell line uacc812  (Procell Inc)
    86
    Procell Inc her2 positive breast cancer cell line uacc812
    Associations between SGLT1 protein expression levels and clinicopathologic variables of the breast cancer patient cohort.
    Her2 Positive Breast Cancer Cell Line Uacc812, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/her2+breast+cancer+cell+lines+uacc812/breast+cancer+cell+human+lines/pmc12343727-106-19-37
    Average 86 stars, based on 1 article reviews
    her2 positive breast cancer cell line uacc812 - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Associations between SGLT1 protein expression levels and clinicopathologic variables of the breast cancer patient cohort.

    Journal: Disease Markers

    Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer

    doi: 10.1155/2020/6103542

    Figure Lengend Snippet: Associations between SGLT1 protein expression levels and clinicopathologic variables of the breast cancer patient cohort.

    Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.

    Techniques: Expressing

    Representative staining of SGLT1 in different subtypes of breast cancer (×100, ×400). (a) Negative immunoreactions. Scale bar: 100 μ m. (b) Positive staining of SGLT1 in luminal-like breast cancer. (c) Positive staining of SGLT1 in HER2+ breast cancer. (d) Positive staining of SGLT1 in basal-like breast cancer.

    Journal: Disease Markers

    Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer

    doi: 10.1155/2020/6103542

    Figure Lengend Snippet: Representative staining of SGLT1 in different subtypes of breast cancer (×100, ×400). (a) Negative immunoreactions. Scale bar: 100 μ m. (b) Positive staining of SGLT1 in luminal-like breast cancer. (c) Positive staining of SGLT1 in HER2+ breast cancer. (d) Positive staining of SGLT1 in basal-like breast cancer.

    Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.

    Techniques: Staining

    Representative western blot of HER2 and SGLT1 expression levels and quantification relative to actin in UACC812 and SKBR3 cells. UACC812 and SKBR3 cells were treated with HER2 inhibitors (HER2 I), Phlorizin, MG132 alone, or in combination for 48 h. Untreated cells were used as a negative control (NC). (a) A representative WB detection result of three independent experiments was shown. (b) The relative levels of HER2 and SGLT1 protein in UACC812 and SKBR3 cells. Statistically significant differences between groups were displayed; ∗∗∗∗ p < 0.0001; ∗∗∗ p < 0.001; ∗∗ p < 0.01; ∗ p < 0.05.

    Journal: Disease Markers

    Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer

    doi: 10.1155/2020/6103542

    Figure Lengend Snippet: Representative western blot of HER2 and SGLT1 expression levels and quantification relative to actin in UACC812 and SKBR3 cells. UACC812 and SKBR3 cells were treated with HER2 inhibitors (HER2 I), Phlorizin, MG132 alone, or in combination for 48 h. Untreated cells were used as a negative control (NC). (a) A representative WB detection result of three independent experiments was shown. (b) The relative levels of HER2 and SGLT1 protein in UACC812 and SKBR3 cells. Statistically significant differences between groups were displayed; ∗∗∗∗ p < 0.0001; ∗∗∗ p < 0.001; ∗∗ p < 0.01; ∗ p < 0.05.

    Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.

    Techniques: Western Blot, Expressing, Negative Control

    The curve and column results of the ECAR values for UACC812 and SKBR3 cells. (a) The ECAR values of UACC812 and SKBR3 cells treated with 0, 10, 20, 30, 40, 50, and 60 min, respectively. (b) The ECAR values of each group at 40 min in UACC812 and SKBR3 cells. Statistically significant differences between groups were displayed; ∗∗∗∗ p < 0.0001; ∗∗∗ p < 0.001; ∗∗ p < 0.01.

    Journal: Disease Markers

    Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer

    doi: 10.1155/2020/6103542

    Figure Lengend Snippet: The curve and column results of the ECAR values for UACC812 and SKBR3 cells. (a) The ECAR values of UACC812 and SKBR3 cells treated with 0, 10, 20, 30, 40, 50, and 60 min, respectively. (b) The ECAR values of each group at 40 min in UACC812 and SKBR3 cells. Statistically significant differences between groups were displayed; ∗∗∗∗ p < 0.0001; ∗∗∗ p < 0.001; ∗∗ p < 0.01.

    Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.

    Techniques:

    Representative western blot of PI3K/Akt/mTOR pathway-related protein expression levels and quantification relative to actin in UACC812 cells. A representative WB detection result of PI3K/Akt/mTOR pathway-related protein expression levels in (a) SGLT1 siRNA and (d) phlorizin treatment. The relative levels of PI3K/Akt/mTOR protein in (b) SGLT1 siRNA and (e) phlorizin treatment. The relative levels of p-PI3K/p-Akt/p-mTOR protein in (c) SGLT1 siRNA and (f) phlorizin treatment. The results shown were representative of at least three independent experiments; ∗∗∗∗ p < 0.0001.

    Journal: Disease Markers

    Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer

    doi: 10.1155/2020/6103542

    Figure Lengend Snippet: Representative western blot of PI3K/Akt/mTOR pathway-related protein expression levels and quantification relative to actin in UACC812 cells. A representative WB detection result of PI3K/Akt/mTOR pathway-related protein expression levels in (a) SGLT1 siRNA and (d) phlorizin treatment. The relative levels of PI3K/Akt/mTOR protein in (b) SGLT1 siRNA and (e) phlorizin treatment. The relative levels of p-PI3K/p-Akt/p-mTOR protein in (c) SGLT1 siRNA and (f) phlorizin treatment. The results shown were representative of at least three independent experiments; ∗∗∗∗ p < 0.0001.

    Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.

    Techniques: Western Blot, Expressing

    CCK-8 assays for the effect of SGLT1 expression on cell proliferation in UACC812 and SKBR3 cells. (a) The cell viability of UACC812 and SKBR3 cells relative to negative control groups after 0, 12, 24, 36, and 48 h treatment, respectively. (b) The cell viability of each group relative to negative control groups at 48 h in UACC812 and SKBR3 cells. Statistically significant differences between groups were displayed; ∗∗∗∗ p < 0.0001; ∗∗∗ p < 0.001; ∗∗ p < 0.01; ∗ p < 0.05.

    Journal: Disease Markers

    Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer

    doi: 10.1155/2020/6103542

    Figure Lengend Snippet: CCK-8 assays for the effect of SGLT1 expression on cell proliferation in UACC812 and SKBR3 cells. (a) The cell viability of UACC812 and SKBR3 cells relative to negative control groups after 0, 12, 24, 36, and 48 h treatment, respectively. (b) The cell viability of each group relative to negative control groups at 48 h in UACC812 and SKBR3 cells. Statistically significant differences between groups were displayed; ∗∗∗∗ p < 0.0001; ∗∗∗ p < 0.001; ∗∗ p < 0.01; ∗ p < 0.05.

    Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.

    Techniques: CCK-8 Assay, Expressing, Negative Control

    Cox's univariate regression analysis of the patient survival in breast cancer with respect to clinical parameters and cancer biological factors.

    Journal: Disease Markers

    Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer

    doi: 10.1155/2020/6103542

    Figure Lengend Snippet: Cox's univariate regression analysis of the patient survival in breast cancer with respect to clinical parameters and cancer biological factors.

    Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.

    Techniques:

    Kaplan-Meier survival analysis according to SGLT1 expression in the whole cohort and HER2+ subtype of breast cancer patients (log-rank test). Association of SGLT1 expression levels with (a) DFS and (c) OS in the whole cohort of breast cancer patients. Association of SGLT1 expression levels with (b) DFS and (d) OS in HER2+ breast cancer patients.

    Journal: Disease Markers

    Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer

    doi: 10.1155/2020/6103542

    Figure Lengend Snippet: Kaplan-Meier survival analysis according to SGLT1 expression in the whole cohort and HER2+ subtype of breast cancer patients (log-rank test). Association of SGLT1 expression levels with (a) DFS and (c) OS in the whole cohort of breast cancer patients. Association of SGLT1 expression levels with (b) DFS and (d) OS in HER2+ breast cancer patients.

    Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.

    Techniques: Expressing

    Kaplan-Meier survival analysis according to SGLT1 expression in basal-like, luminal-like, and luminal-HER2+ subtype of breast cancer patients (log-rank test). Association of SGLT1 expression levels with (a) DFS and (d) OS in basal-like breast cancer patients. Association of SGLT1 expression levels with (b) DFS and (e) OS in luminal-like breast cancer patients. Association of SGLT1 expression levels with (c) DFS and (f) OS in LuminalHER2+ breast cancer patients.

    Journal: Disease Markers

    Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer

    doi: 10.1155/2020/6103542

    Figure Lengend Snippet: Kaplan-Meier survival analysis according to SGLT1 expression in basal-like, luminal-like, and luminal-HER2+ subtype of breast cancer patients (log-rank test). Association of SGLT1 expression levels with (a) DFS and (d) OS in basal-like breast cancer patients. Association of SGLT1 expression levels with (b) DFS and (e) OS in luminal-like breast cancer patients. Association of SGLT1 expression levels with (c) DFS and (f) OS in LuminalHER2+ breast cancer patients.

    Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.

    Techniques: Expressing

    Cox's multivariate regression analysis of the patient survival in breast cancer with respect to clinical parameters and cancer biological factors.

    Journal: Disease Markers

    Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer

    doi: 10.1155/2020/6103542

    Figure Lengend Snippet: Cox's multivariate regression analysis of the patient survival in breast cancer with respect to clinical parameters and cancer biological factors.

    Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.

    Techniques: